Trichlormethiazide - Generic Drug Details

What are the generic drug sources for trichlormethiazide and what is the scope of patent protection?

Trichlormethiazide is the generic ingredient in five branded drugs marketed by Sanofi Aventis Us, Schering, Lannett, Mast Mm, Chartwell Rx, Impax Labs, Par Pharm, Sandoz, and Watson Labs, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

Summary for trichlormethiazide

US Patents:	0
Tradenames:	5
Applicants:	9
NDAs:	15
Raw Ingredient (Bulk) Api Vendors:	84
Patent Applications:	7,404
DailyMed Link:	trichlormethiazide at DailyMed

Medical Subject Heading (MeSH) Categories for trichlormethiazide

Antihypertensive Agents

Diuretics

Sodium Chloride Symporter Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for trichlormethiazide

C03AA	Thiazides, plain
C03A	LOW-CEILING DIURETICS, THIAZIDES
C03	DIURETICS
C	Cardiovascular system

US Patents and Regulatory Information for trichlormethiazide

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Par Pharm	TRICHLORMETHIAZIDE	trichlormethiazide	TABLET;ORAL	087007-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Chartwell Rx	TRICHLORMETHIAZIDE	trichlormethiazide	TABLET;ORAL	085568-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Watson Labs	TRICHLORMETHIAZIDE	trichlormethiazide	TABLET;ORAL	086458-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Sanofi Aventis Us	METAHYDRIN	trichlormethiazide	TABLET;ORAL	012594-002	Jun 16, 1988		DISCN	No	No
Schering	NAQUA	trichlormethiazide	TABLET;ORAL	012265-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Sandoz	TRICHLORMETHIAZIDE	trichlormethiazide	TABLET;ORAL	086171-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Schering	NAQUA	trichlormethiazide	TABLET;ORAL	012265-001	Approved Prior to Jan 1, 1982		DISCN	No	No